| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/12/2008 | CA2174236C Superoxide dismutase and mimetics thereof |
| 02/12/2008 | CA2172778C Cgrp antagonist used for the treatment of lichen and pruritus; composition thus produced |
| 02/12/2008 | CA2163196C Regulation of antigen presentation |
| 02/12/2008 | CA2151957C Aqueous pharmaceutical preparations of g-csf which are stable in storage |
| 02/12/2008 | CA2151732C Stable lyophilized pharmaceutical preparations of g-csf |
| 02/12/2008 | CA2133982C Ligand for the c-kit receptor and methods of use thereof |
| 02/12/2008 | CA2131729C Helicobacter pylori proteins useful for vaccines and diagnostics |
| 02/12/2008 | CA2131153C Peptides stimulating cytotoxic lymphocytes response to hiv-i gp 160 |
| 02/08/2008 | CA2596467A1 Dendroaspis natriuretic peptide |
| 02/07/2008 | WO2008016890A1 Antitumorigenic drug combination |
| 02/07/2008 | WO2008016842A1 Topical skin compositions, their preparation, and their use |
| 02/07/2008 | WO2008016793A2 Methods, compositions and articles of manufacture for contributing to the treatment of cancers |
| 02/07/2008 | WO2008016729A1 Compositions for intranasal delivery of human insulin and uses thereof |
| 02/07/2008 | WO2008016711A2 Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives |
| 02/07/2008 | WO2008016554A1 Mitochondria-targeted antioxidants |
| 02/07/2008 | WO2008016490A2 Modified two-component gelation systems for the treatment of post-myocardial infarction |
| 02/07/2008 | WO2008016431A2 Bi-specific monoclonal antibody (specific for both cd3 and cd11b) therapeutic drug |
| 02/07/2008 | WO2008016404A2 Parathyroid hormone analogues and uses thereof |
| 02/07/2008 | WO2008016314A1 Myostatin antagonists |
| 02/07/2008 | WO2008016282A1 Method of regulating mammalian target-of-rapamycin activity by interaction between phospholipase d and rheb |
| 02/07/2008 | WO2008016281A1 Method of regulating mammalian target-of-rapamycin activity by interaction between phospholipase d and raptor |
| 02/07/2008 | WO2008016163A1 Crosslinked gelatin gel multilayered structure, carrier for bioactive factor, preparation for release of bioactive factor, and their production methods |
| 02/07/2008 | WO2008016141A1 Kif-derived peptide capable of binding to hla-a24 molecule |
| 02/07/2008 | WO2008015850A1 Composition for prevention and amelioration of metabolic syndrome |
| 02/07/2008 | WO2008015841A1 Kinase-inhibiting fused protein and pharmaceutical composition |
| 02/07/2008 | WO2008015720A2 PEPTIDE DERIVED FROM VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1 BINDING INTEGRIN α5β1, HAVING PROANGIOGENIC ACTIVITY |
| 02/07/2008 | WO2008015425A2 Mhc oligomers, components thereof, and methods of making the same |
| 02/07/2008 | WO2008015383A2 Bmp-9 and bmp-10 and their use in breast and prostate cancer therapies |
| 02/07/2008 | WO2008015344A2 Dermatological and/or cosmetic composition containing polypeptides or peptides of the protein slc24a5 |
| 02/07/2008 | WO2008015339A2 Recombinant factor vii composition |
| 02/07/2008 | WO2008015319A1 Implantable preparation, useful more particularly for tissue complement and cicatrisation |
| 02/07/2008 | WO2008015275A1 Fractions of whey permeate and its use for the prevention and therapy of type 2 diabetes and the metabolic syndrome |
| 02/07/2008 | WO2008015273A1 Cd4-receptor-derived peptides and method for the preparation thereof |
| 02/07/2008 | WO2008015199A1 Chemokine antagonists |
| 02/07/2008 | WO2008015023A2 Use of photomedin products for preventing and/or treating neuronal dysfunctions |
| 02/07/2008 | WO2008015014A2 Cystatin from nematodes in the treatment of autoimmune or allergic diseases |
| 02/07/2008 | WO2008014917A1 Fusion peptide for inhibiting interaction of neuronal nmda receptor (nmdar) and nmdar interacting proteins |
| 02/07/2008 | WO2008014668A1 Attenuated salmonella carrying effective plasmid and its antitumorigenic use |
| 02/07/2008 | WO2008014613A1 Multifunctional bioactive compounds |
| 02/07/2008 | WO2008014612A1 Fusion proteins and methods for modulation of immune response |
| 02/07/2008 | WO2008014603A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/07/2008 | WO2008014574A1 Cleavage of bip by subtilase cytotoxin |
| 02/07/2008 | WO2008014555A1 Method of identifying cd4+cd25+ t cells activated to an antigen which express cd8 |
| 02/07/2008 | WO2007148345A3 A method of producing biologically active polypeptide having insulinotropic activity |
| 02/07/2008 | WO2007147630A3 Peptides regulating the surface expression of the t cell receptor |
| 02/07/2008 | WO2007142542A3 Cationic milk proteins for treating mastitis |
| 02/07/2008 | WO2007140230A3 Methods of use and nutritional compositions of touchi extract |
| 02/07/2008 | WO2007139767A3 Compositions and methods for the delivery of nitric oxide |
| 02/07/2008 | WO2007138455A3 Polypeptides derived from the hemopexin-like domain of metalloproteinase mmp-2 |
| 02/07/2008 | WO2007113683A3 Modulation of tc10 function and method of treating glucose metabolic disorders |
| 02/07/2008 | WO2007113633A3 Immunogenic compositions comprising cat allergen fel dl |
| 02/07/2008 | WO2007110385A3 Coronin 1 modulators for the treatment of autoimmune and lymphoproliferative disorders and mycobacterial infections |
| 02/07/2008 | WO2007102957B1 Skin care compositions including hexapeptide complexes and methods of their manufacture |
| 02/07/2008 | WO2007098500A3 A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
| 02/07/2008 | WO2007084544A3 Methods of treating or preventing tissue damage caused by increased blood flow |
| 02/07/2008 | WO2007072042A3 Identification of apoptosis inducing proteins |
| 02/07/2008 | WO2007059491A8 Novel hydrogels and uses thereof |
| 02/07/2008 | WO2007052326B1 Method for conversion of uric acid to allantoin and related enzymes |
| 02/07/2008 | WO2007008220A8 Gene or drug delivery system |
| 02/07/2008 | WO2006044063A3 Transepithelial delivery of peptides with incretin hormone activities |
| 02/07/2008 | US20080033331 Solid dressing for treating wounded tissue |
| 02/07/2008 | US20080033204 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
| 02/07/2008 | US20080033149 Human anti-TNF antibodies and peptides |
| 02/07/2008 | US20080033061 Cation conducting gabaa receptors and their use |
| 02/07/2008 | US20080033046 Treatment of myocardial infarction with 11HSD1 inhibitors |
| 02/07/2008 | US20080033003 Camptothecins Conjugated in Position 7 to Cyclic Peptides as Cytostatic Agents |
| 02/07/2008 | US20080032996 Substituted Quinazoline or Pyridopyrimidine Derivative |
| 02/07/2008 | US20080032945 2'-modified oligonucleotides |
| 02/07/2008 | US20080032942 double-stranded (siNA) molecule that down-regulates expression of a beta-secretase (BACE) gene |
| 02/07/2008 | US20080032936 Quinoxalinyl tripeptide hepatitis C virus inhibitors |
| 02/07/2008 | US20080032935 Application of initial doses of lhrh analogues and maintenance doses of lhrh antagonists for the treatment of hormone-dependent cancers and corresponding pharmaceutical kits |
| 02/07/2008 | US20080032934 Compositions for prevention of adhesions and other barrier applications |
| 02/07/2008 | US20080032933 Type V Phosphodiesterase Inhibitors and Natriuretic Polypeptides |
| 02/07/2008 | US20080032932 Method of reducing mortality and morbidity associated with critical illnesses |
| 02/07/2008 | US20080032931 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules |
| 02/07/2008 | US20080032930 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules |
| 02/07/2008 | US20080032929 N-terminal truncation of cardiac troponin subunits and their roles in cardiovascular disease |
| 02/07/2008 | US20080032928 Treatment of mucus hypersecretion |
| 02/07/2008 | US20080032927 Treatment of development-related disorders |
| 02/07/2008 | US20080032926 Knockout Non-Human Animal |
| 02/07/2008 | US20080032925 Method for Modulating Inflammatory Responses by Altering Plasma Lipid Levels |
| 02/07/2008 | US20080032924 Antifungal Peptides |
| 02/07/2008 | US20080032923 Effective Use Method Of Medicaments And Method Of Preventing Expression Of Side Effect |
| 02/07/2008 | US20080032922 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression |
| 02/07/2008 | US20080032921 Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions |
| 02/07/2008 | US20080032920 Macromolecules modified with electrophilic groups and methods of making and using thereof |
| 02/07/2008 | US20080032919 BMP-7 Variant Compositions, Methods and Uses |
| 02/07/2008 | US20080032918 Gene expression or biosynthesis inhibition by locally administering inhibitors of angiotensin-converting enzyme, angiotensin type 1 receptors, or sodium-hydrogen exchange type-1 proteins; antiinflammatory agents, myocardial antiischemic agents, anaphylaxis; sustained release implants, stents, inhalers |
| 02/07/2008 | US20080032917 Flavivirus protease substrates and inhibitors |
| 02/07/2008 | US20080032916 Preparation for Use of Aspartate and Vitamin B12 or Biotin for Regulating Ketone Bodies |
| 02/07/2008 | US20080032915 Cysteine Rich Peptides for Improving Thiol Homeostasis |
| 02/07/2008 | US20080032385 Novel antimicrobial peptide isolated from Penaeus monodon |
| 02/07/2008 | US20080032337 Genetic engineering; analyze the corresponding expression products, elucidate the pathology of diseases associated with the genes, for example hereditary diseases and cancer, and diagnose and treat such diseases |
| 02/07/2008 | US20080032336 Chemokine receptor materials and methods |
| 02/07/2008 | US20080032333 Polynucleotides encoding soluble zalpha11 cytokine receptors |
| 02/07/2008 | US20080032332 Wound healing agents; anticancer agents; cardiovascular disorders |
| 02/07/2008 | US20080032320 Method of Screening Compound Capable of Accelerating or Inhibiting Apoptosis, Apoptosis Accelarator and Apoptosis Inhibitor |
| 02/07/2008 | US20080032314 Use of VEGF and homologuest to treat neuron disorders |
| 02/07/2008 | US20080032289 Novel TWIK-6, TWIK-7, IC23927, TWIK-8, IC47611, IC47615, HNMDA-1, TWIK-9, alpha2delta-4, 8099, 46455, 54414, 53763, 97076, 97102, 44181, 67084Fl and 67084alt molecules and uses therefor |
| 02/07/2008 | US20080031970 Method of Promoting Natural Bypass |